Wound Care Therapy Devices Market Size & Share 2025 – 2034

Wound Care Therapy Devices Market Size

The global wound care therapy devices market was estimated at USD 2.1 billion in 2024. The market is expected to grow from USD 2.2 billion in 2025 to USD 3.4 billion in 2034, growing at a CAGR of 5.1% according to the latest report published by Global Market Insights Inc.

The growth of the global wound care therapy devices market is largely influenced by the increasing number of surgical procedures, surge in government initiatives regarding wound care treatment, and technological advancements in wound care, which is estimated to reach USD 44.2 billion by 2034, devices. Wound care therapy devices are specialized medical technologies designed to support and accelerate the healing of acute and chronic wounds.
 

The market grew from USD 1.8 billion in 2021 to USD 2 billion in 2023. This growth is primarily accelerated by the increasing number of surgical procedures worldwide. The rise in surgeries creates a direct demand for wound care therapy devices, as these procedures require effective post-operative wound management. In the U.S., approximately 4.3 million elective procedures occur monthly, with 47% involving surgery. Furthermore, the International Society of Aesthetic Plastic Surgery (ISAPS) global survey reports that the U.S. leads globally in plastic surgeries, with over 7.4 million procedures in 2022. The increase in both emergency and elective surgeries has enhanced the demand for wound therapy devices for the management of surgical wounds, making them essential in modern surgical care.
 

Moreover, the increasing prevalence of chronic wounds significantly stimulates the wound care therapy devices market, especially in aging populations. While chronic wounds, such as pressure ulcers, commonly affect older individuals, recent studies show increased cases among people over 65. According to the National Library of Medicine, chronic wounds affect approximately 2% of the total U.S. population, with 3% of individuals over 65 experiencing open wounds. With the U.S. elderly population expected to reach 94.7 million by 2060, chronic wound cases are projected to increase substantially. This demographic shift highlights the need for advanced wound care therapy devices to promote healing, minimize complications, and enhance patient quality of life across age groups, thereby propelling the market growth.
 

Wound care therapy devices are specialized medical technologies designed to support and accelerate the healing of acute and chronic wounds. These devices go beyond basic wound dressings by actively managing the wound environment through mechanisms such as suction, pressure modulation, oxygen delivery, or electrical stimulation to promote tissue regeneration, reduce infection risk, and improve patient outcomes.
 

Wound Care Therapy Devices Market Trends

• Technological innovations have introduced smart wound care systems that monitor moisture levels, temperature, and infection markers in real time. These devices help clinicians make timely decisions, improving healing outcomes and reducing complications.
   
• For instance, Solventum’s Veraflo therapy with cleanse choice dressings is a notable example of advanced wound care solution that combines negative pressure wound therapy (NPWT) with automated instillation and cleansing. The system streamlines wound bed preparation and minimizes manual intervention, leading to faster healing and improved clinical outcomes. By enhancing treatment efficiency and reducing hospital stays, Veraflo supports the growing demand for innovative, cost-effective wound care solutions.
   
• Additionally, modern wound therapy devices, especially portable NPWT systems, allow patients to receive treatment outside hospital settings. This helps homecare and outpatient recovery, reducing hospital stays and healthcare costs.
   
• Moreover, the increasing prevalence of diabetes significantly impacts market growth, as diabetic patients face elevated risks of developing foot ulcers. For instance, according to the International Diabetes Federation (IDF), the global diabetic population reached 537 million in 2021 and is expected to increase to 643 million by 2030 and 783 million by 2045.
   
• Thus, the rising diabetes prevalence directly correlates with increased diabetic foot ulcer risks, accelerating the demand for advanced wound therapy devices and subsequent market expansion.
   

Wound Care Therapy Devices Market Analysis

Based on the product, the wound care therapy devices market is segmented into negative pressure wound therapy, oxygen and hyperbaric oxygen equipment, electric stimulation devices, pressure relief devices, and other wound therapy devices. The negative pressure wound therapy (NPWT) segment held a significant market share of 49% in 2024.
 

• Negative pressure wound therapy (NPWT) supports the formation of granulation tissue by drawing the edges of the wound together and improving circulation at the wound site, thereby speeding up the healing process.
   
• By extracting excess fluids, exudates, and harmful bacteria, NPWT plays a crucial role in reducing the risk of infection, particularly in vulnerable wounds such as those resulting from surgery or trauma.
   
• For instance, the Avelle NPWT System by Convatec is a compact and lightweight device that delivers negative pressure therapy. It helps maintain proper moisture levels, reduces the frequency of dressing changes, and lowers the chances of infection, all while enabling patients to stay active and comfortable.
   
• NPWT preserves a moist wound environment, which is essential for effective healing. It prevents the wound from becoming too dry or overly saturated, both of which can impede recovery.
   
• Additionally, it helps decrease swelling (edema) by removing fluids from the wound area, easing pressure, and enhancing both healing conditions and patient comfort.
   
• NPWT systems require fewer dressing changes, which minimizes disruption to the wound and reduces pain, and improves patient convenience and comfort throughout the recovery period, thereby propelling this device adoption in healthcare for complex wound management, propelling the segment's growth.
   

Based on application, the wound care therapy devices market is segmented into chronic wounds and acute wounds. The chronic wound segment is further bifurcated into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. The chronic wound segment held a market size of USD 837.7 million in 2024.  
 

• This growth is driven by the rising prevalence of chronic conditions such as diabetes, obesity, and vascular disorders, which significantly increase the risk of non-healing wounds.
   
• For instance, according to the American Diabetes Association, people with diabetes are at high risk of developing foot problems due to nerve damage (neuropathy), poor circulation, and reduced ability to heal wounds. These complications often lead to chronic ulcers, infections, and in severe cases amputations.
   
• For instance, according to the American Diabetes Association (ADA), globally, it is estimated that 19% to 34% of people living with diabetes will develop a diabetic foot ulcer (DFU) in their lifetime. These ulcers are not only difficult to treat but also carry a high risk of recurrence and mortality, making them a critical focus for advanced wound care interventions.
   
• The ADA further highlights that approximately 20% of individuals with a DFU will require a lower-extremity amputation, and 10% will die within one year of their first DFU diagnosis. These statistics emphasize the necessity for advanced wound care therapy devices to improve patient outcomes.
   

• Further, technological advancements are reshaping chronic wound management. Innovations such as negative pressure wound therapy (NPWT), and active therapies are improving healing outcomes and reducing treatment durations. For instance, NPWT has demonstrated a reduction in healing time for certain chronic wounds.
   
• Therefore, chronic wound segment is witnessing strong growth, due to rising chronic conditions, and technological innovations that are improving treatment outcomes and accessibility.
   

Based on end use, the wound care therapy devices market is categorized into hospitals, specialty clinics, home care setting, and other end users. Hospitals segment dominated the market in 2024, accounting for 42.6% of the market share. This dominance is projected to continue, with the segment expected to reach USD 1.5 billion by 2034.
 

• Hospitals remain the largest and most dominant end-user segment in the wound care therapy devices market. They act as primary centres for managing acute, surgical, and chronic wounds. These institutions are one stop destination for wide range of therapy devices, including negative pressure wound therapy (NPWT) systems, electrical stimulation units, and advanced oxygen therapy devices.
   
• The high volume of surgical interventions, trauma cases, and complex wound care needs in inpatient settings drives consistent demand for clinically proven and technologically advanced wound care solutions.
   
• In hospital environments, wound care therapy devices are utilized across various departments such as emergency care, surgical units, burn centres, and intensive care units.
   
• Moreover, tertiary care centres are increasingly adopting advanced wound therapy devices to improve healing outcomes, minimize hospital stays, and reduce the risk of hospital-acquired infections.
   
• Therefore, as global healthcare infrastructure continues to evolve and the burden of chronic and complex wounds increases, hospitals are expected to maintain their dominant role in the market.
   

North America Wound Care Therapy Devices Market
 

The North America market dominated the market with a market share of 36.7% in 2024. The U.S. market was valued at USD 616.1 million and USD 642.5 million in 2021 and 2022, respectively. The market size reached USD 697.4 million in 2024, growing from USD 669.3 million in 2023.
 

• The U.S. wound care therapy devices market is experiencing significant growth due to the rising incidence of diabetes across the country. Diabetes is a considerable risk factor for chronic wounds, particularly diabetic foot ulcers (DFUs), which often require advanced wound management solutions such as negative pressure wound therapy (NPWT).
   
• According to the Centers for Disease Control and Prevention (CDC), in 2021, approximately 38.4 million people of all ages in the U.S., which is equivalent to 11.6% of the total U.S. population, were living with diabetes. These figures highlight the scale of the challenge and the growing need for wound therapy devices tailored to diabetic patients with foot ulcers, particularly in hospital, outpatient, and home care settings.
   
• Thus, as the diabetic population continues to grow, so does the risk of developing diabetic foot ulcers among patients, in turn accelerating the demand for effective, technology-driven wound care devices that reduce healing time, prevent complications, and lower healthcare costs, fostering the market growth in the country
   

Europe Wound Care Therapy Devices Market
 

Europe market accounted for USD 613.1 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The European market is seeing consistent growth, largely influenced by the increasing prevalence of diabetes across the region.
   
• For instance, according to International Diabetes Federation (IDF), in Europe, the number of adults aged 20 to 79 with diabetes has nearly tripled over the past two decades from 22.4 million in 2000 to 65.6 million in 2024. Projections suggest this figure will reach 72.4 million by 2050.
   
• Thus, the growing diabetic population, a significant contributor to chronic wounds such as diabetic foot ulcers (DFUs), has increased the demand for advanced wound care technologies, including NPWT systems.
   
• Healthcare providers in hospitals across the region are adopting more effective wound management solutions to enhance healing outcomes and minimize complications, thereby propelling the market growth in the region.
   

Germany wound care therapy devices market is anticipated to witness considerable growth over the analysis period.
 

• The Germany market is experiencing steady growth, significantly influenced by the increasing incidence of chronic wounds, particularly pressure ulcers.
   
• These wounds, often associated with prolonged immobility and aging populations, require advanced wound care interventions such as negative pressure wound therapy (NPWT), specialized dressings, and pressure-relieving systems.
   
• According to the IQTIG quality indicators report for 2020, 21.6% of pressure ulcers treated in German hospitals were not present at the time of admission, indicating a high rate of hospital-acquired pressure injuries. In 2021 alone, over 395,980 pressure ulcers were treated in Germany, with more than 82,000 cases likely originating during hospitalization. Over the past decade, pressure ulcers have also contributed to significant mortality in Germany. Between 2012 and 2021, an average of 743 patients per year died from complications related to pressure ulceration.
   
• Therefore, as the burden of chronic wounds continues to rise in the country, so does the demand for effective and efficient wound therapy devices across hospitals, outpatient clinics, and long-term care facilities.
   

Asia Pacific Wound Care Therapy Devices Market
 

The Asia Pacific market is anticipated to grow at the CAGR of 5.7% during the analysis timeframe.
 

• The Asia Pacific wound care therapy devices market is witnessing significant growth, primarily stimulated by the increasing prevalence of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers.
   
• These conditions are becoming more common due to aging populations, sedentary lifestyles, and the rising incidence of diabetes and vascular diseases across the region. As healthcare systems in countries such as China, Japan, and Australia shift focus toward advanced wound management, the demand for innovative wound care therapy devices is accelerating the market growth.
   

Japan wound care therapy devices market is predicted to grow significantly over the forecast period.
 

• The Japan market is experiencing steady growth, largely propelled by rapid technological advancements. Innovations in advanced wound management technology, such as negative pressure wound therapy (NPWT), bioengineered skin substitutes, and AI-driven wound assessment tools are transforming traditional wound care practices. These technologies not only accelerate healing but also reduce infection risks and improve patient comfort.
   
• Thus, technological advancements are helping Japan’s market to grow. These innovations are improving clinical outcomes and reshaping the patient experience by offering faster, safer, and more accessible care.
   

Latin America Wound Care Therapy Devices Market
 

Brazil is experiencing significant growth in the Latin America market.
 

• The market in Brazil is witnessing significant growth, due to the rising prevalence of chronic wounds. Factors such as an aging population, and a surge in chronic conditions such as diabetes and vascular diseases are contributing to a higher incidence of non-healing wounds. This has created a growing demand for advanced wound care solutions, including negative pressure wound therapy (NPWT).
   
• Healthcare providers across Brazil are increasingly adopting these technologies to improve healing outcomes, reduce hospital stays, and lower the risk of complications.
   
• For instance, according to the International Diabetes Federation (IDF), Brazil had over 16.6 million adults living with diabetes in 2024, representing a 10.6% prevalence among its 155 million adult population. This increase in diabetes cases is directly linked to a higher incidence of diabetic foot ulcers and other chronic wounds, creating pressure on the healthcare system and accelerating the need for effective wound care therapy devices.
   

Middle East and Africa Wound Care Therapy Devices Market
 

Saudi Arabia market is poised to witness substantial growth in the Middle East and Africa market during the forecast period.
 

• The market in Saudi Arabia is expanding rapidly, driven by the increasing prevalence of diabetic foot ulcers (DFUs). The rising incidence of DFUs in the country has prompted healthcare providers and policymakers to invest in advanced wound care technologies such as negative pressure wound therapy and smart dressings to improve patient outcomes and reduce healthcare costs.
   
• According to the 2024 National Institutes of Health (NIH) report, in Saudi Arabia, among individuals with poorly controlled type 2 diabetes mellitus (T2DM), 81% experienced foot ulcers, 31% underwent foot amputations, and 29% developed gangrene. Other complications included bone deformities (22%), ingrown toenails (17%), Charcot’s foot (10%), and calluses (9%).
   
• Additionally, a significant proportion of patients suffered from comorbidities such as hypertension, anaemia, diabetic peripheral neuropathy (affecting about 50%), diabetic nephropathy (33%), and diabetic retinopathy (14%). These statistics underscore the urgent need for effective wound care interventions tailored to the unique health challenges of the Saudi population, thereby propelling the market growth in the country.
   

Wound Care Therapy Devices Market Share

• Top 5 players, Smith & Nephew, Mölnlycke Health Care, Solventum, ConvaTec and Cardinal Health account for a market share of 58% and are also expanding their global footprint through strategic initiatives. These include mergers, acquisitions, and innovation-driven partnerships aimed at strengthening their long-term competitiveness in the evolving market.
   
• These companies are actively integrating advanced wound healing technologies into their product portfolios. By embedding digital monitoring tools and enabling remote wound management, they are enhancing the efficacy, precision, and scalability of wound care delivery.
   
• Collaborations with healthcare providers and regulatory bodies are central to their strategy, ensuring that wound care solutions meet evolving clinical standards and patient safety requirements. Additionally, initiatives to improve access in underserved and aging populations are making advanced wound care more inclusive and impactful across diverse healthcare systems.
   
• Through technology-driven innovation, these market leaders are transforming wound management by improving healing outcomes, reducing hospital stays, and lowering the risk of complications. Their focus on patient-centric, evidence-based wound care is reshaping clinical protocols, enhancing quality of life, and contributing to more sustainable healthcare systems worldwide.
   

Wound Care Therapy Devices Market Companies

Some of the eminent market participants operating in the wound care therapy devices solutions industry include:

• Accel-Heal Technologies
• Cardinal Health
• ConvaTec
• DeRoyal Industries
• Medaxis
• Mölnlycke Health Care
• Sky Medical Technology
• Smith+Nephew
• Solventum
• Talley Group
• WoundEL Health Care
   
• Mölnlycke Health Care

Mölnlycke Health Care is a medical solutions company with a strong global presence in the wound care therapy devices market. It is known for its focus on advanced wound management, particularly in foam dressings and pressure ulcer prevention. The company continues to invest in innovation and sustainability, aiming to improve healing outcomes while reducing the overall cost and environmental impact of wound care.
 

• Cardinal Health

Cardinal Health is a major healthcare services and products company with a growing presence in the wound care therapy devices market. The company offers a broad range of solutions tailored for both acute and chronic wound management, serving hospitals, clinics, and home care settings. With a focus on innovation and accessibility, Cardinal Health continues to expand its wound care portfolio, supporting improved healing outcomes through advanced technologies and integrated care delivery.
 

• Accel-Heal Technologies

Accel-Heal Technologies Limited is a UK-based medical technology company dedicated to advancing innovative solutions for wound care. The company specializes in the development and commercialization of unique electrical stimulation products designed to improve clinical outcomes and reduce healthcare costs for patients with painful, hard-to-heal wounds.
 

Wound Care Therapy Devices Industry News

• In April 2024, 3M officially completed the spin-off of its Health Care business, launching Solventum Corporation as an independent company listed on the New York Stock Exchange (NYSE) under the ticker symbol SOLV. This strategic move allows both 3M and Solventum to pursue focused growth and capital allocation strategies tailored to their respective markets.
   
• In November 2023, Medela announced the spin-off of its wound care division into a standalone global business through a strategic merger with Swiss med-tech firm Medaxis, part of Olle Larsson Holding. The new entity will continue offering Medela’s advanced wound care solutions, including its Negative Pressure Wound Therapy (NPWT) systems, while integrating Medaxis’s latest technologies. The move reinforced innovation and sharpened the focus on the wound care segment, while expanding global reach and accelerating product development in vacuum-assisted wound healing.
   

The wound care therapy devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product         

• Negative pressure wound therapy
• Oxygen and hyperbaric oxygen equipment
• Electric stimulation devices
• Pressure relief devices
• Other products

Market, By Application

• Chronic wounds
  • Diabetic foot ulcers
  • Pressure ulcers
  • Venous legs ulcers
  • Other chronic wounds
• Acute wounds
  • Surgical wounds
  • Traumatic wounds
  • Burns

Market, By End Use

• Hospitals
• Specialty clinics
• Home care settings
• Other end users      

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE